LENACAPAVIR INJECTION

LENACAPAVIR INJECTION Specification

Brand Name
LENACAPAVIR

Salt Composition
LENACAPAVIR

Indication
HIV

Life Span
24 MONTHS

Dosage Form
463.5

Packaging Type
BOX

Pacakaging (Quantity Per Box)
1

Origin of Medicine
IMPORTED

Drug Type
Injection

Ingredients
enacapavir is a breakthrough, first-in-class HIV capsid inhibitor. Administered as a subcutaneous injection under the skin of the abdomen or thigh twice a year, it is used for both HIV treatment (with other antiretrovirals) and HIV prevention (PrEP). [1, 2, 3, 4, 5] 1. Key Uses & Approvals HIV Prevention (PrEP): Recommended by the World Health Organization and approved in major markets, it is one of the most effective prevention tools available, requiring only two doses a year. [1, 2] HIV Treatment: Marketed as Sunlenca, it is approved for heavily treatment-experienced adults with multi-drug resistant HIV-1 whose current regimens are failing. [1]

Physical Form
Powder

Function
Anti-Viral

Recommended For
ADULTS

Dosage
463.5

Dosage Guidelines
3

Suitable For
Adults

Quantity
1 Pieces

Storage Instructions
COOL

LENACAPAVIR INJECTION Trade Information

Minimum Order Quantity
1 Piece

FOB Port
INDIA

Payment Terms
Cheque, Telegraphic Transfer (T/T), Western Union, Letter of Credit (L/C), Cash Advance (CA)

Supply Ability
100 Pieces Per Month

Delivery Time
2 Days

Sample Available
Yes

Sample Policy
If order is confirmed we will reimburse the sample cost

Packaging Details
BOX

Main Export Market(s)
Middle East, Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Africa

Certifications
GMP

About LENACAPAVIR INJECTION

enacapavir is a breakthrough, first-in-class HIV capsid inhibitor. Administered as a subcutaneous injection under the skin of the abdomen or thigh twice a year, it is used for both HIV treatment (with other antiretrovirals) and HIV prevention (PrEP). [1, 2, 3, 4, 5]

1. Key Uses & Approvals

HIV Prevention (PrEP): Recommended by the World Health Organization and approved in major markets, it is one of the most effective prevention tools available, requiring only two doses a year. [1, 2]
HIV Treatment: Marketed as Sunlenca, it is approved for heavily treatment-experienced adults with multi-drug resistant HIV-1 whose current regimens are failing. [1]

All Trademarks and Brands that appear on the website belong to their respective owners and We do not lay any claim on them we only provide Information.